HUL Share Price Target 2026: Nuvama cuts to Rs 3,090

What changed for HUL after Q4FY26

Hindustan Unilever Ltd (HUL) reported a broadly encouraging March-quarter (Q4FY26) performance, led by a sharp improvement in volume momentum. Net sales rose 7% year-on-year while volumes increased 6% year-on-year, which the report described as the strongest growth in the past 12 quarters. The quarter marked the company’s second straight period of growth under MD and CEO Priya Nair, helped by traction in premium segments and execution across channels.

But the operating environment is not one-way positive. Broker Nuvama said it remains cautiously optimistic as input-cost inflation is rising while pricing flexibility is limited in the near term. In that context, the brokerage highlighted the risk of margin pressure even as demand recovery and execution-led gains remain visible.

Nuvama’s call: target cut, Buy rating retained

Nuvama maintained a ‘Buy’ rating on HUL, but lowered its target price to Rs 3,090 from Rs 3,200. The brokerage also cut earnings assumptions, trimming EPS estimates by 3% for FY27 and 2% for FY28. The revisions were positioned as a response to the evolving cost and pricing equation, rather than a change in the underlying volume recovery narrative.

For investors, the combination is important. A retained ‘Buy’ suggests Nuvama still sees longer-term merit in the franchise and execution, but the lower target price signals a tighter valuation or profitability outlook than earlier assumed.

Q4FY26 headline performance: volumes lead the recovery

HUL’s Q4FY26 performance was framed as a volume-driven quarter. Net sales growth of 7% year-on-year and volume growth of 6% year-on-year indicate demand traction rather than only price-led expansion. The company also flagged that the quarter reflected a step-up in “on-ground execution” and portfolio transformation, in line with management commentary included in the provided text.

Profit growth looked stronger on a reported basis. One data point in the provided material said Q4FY26 net profit increased 21.4% year-on-year to Rs 2,992 crore. Another excerpt attributed the higher reported profit to divestment proceeds from Nutritional Lab Private Limited in the current quarter and Oziva fair valuation in the base period, suggesting exceptional or one-off effects supported the reported PAT.

Segment trends: Home Care and Beauty & Wellbeing stand out

Growth was described as broad-based across segments, with two divisions specifically highlighted:

• Home Care turnover rose 9% year-on-year, reaching an 11-quarter high.
• Beauty & Wellbeing grew 8% year-on-year, supported by premium products and digital-first brands.

This matters because these categories often anchor HUL’s volume and value mix. The emphasis on premiumisation and digital-first brands also indicates where the company is seeing traction, even as the broader operating backdrop remains sensitive to costs.

Cost pressures: expenses up, EBITDA margin down

The same set of excerpts pointed to a clear cost headwind. HUL’s fourth-quarter expenses rose 8% to Rs 12,934 crore. The EBITDA margin declined 50 basis points to 23.7%.

The combination of higher expenses and lower margin explains why the brokerage focus shifted to near-term profitability risk. Even when volumes improve, a price-cost mismatch can compress margins if price increases cannot fully offset raw material or operating costs.

Dividend: board recommends Rs 22 per share

Alongside its quarterly results, HUL’s board recommended a final dividend of Rs 22 per share, subject to shareholder approval at the upcoming AGM. For investors tracking shareholder payouts, the final dividend recommendation provides a clear event to watch on the corporate calendar.

Stock context: where HUL was trading

The provided material also included a market snapshot from April 2026. HUL was stated to be trading around Rs 2,180 on NSE with a market capitalisation of Rs 5,13,000 crore. The 52-week range was listed as Rs 2,100 (low) to Rs 2,700 (high), with a trailing P/E of approximately 48x.

Separately, one historical snippet referenced early May 2023, when HUL closed at Rs 2,659.10 on NSE, up over 1.36% on the day, and up 5.23% over a four-day stretch.

Key numbers at a glance

Why the margin discussion matters for the 2026 target

Nuvama’s note effectively frames the trade-off HUL faces in the near term: volume momentum looks better, but rising input costs and limited pricing flexibility can cap margin recovery. The cost line already showed stress in Q4FY26, with expenses up 8% and EBITDA margin down to 23.7%. That backdrop helps explain EPS estimate cuts for FY27 and FY28, and the lower target price.

At the same time, the volume and segment indicators show why the brokerage did not abandon its positive stance. The combination of stronger volume growth, traction in premium segments, and execution improvements supports the view that HUL’s demand engine is improving, even if profitability needs monitoring.

Conclusion

HUL’s Q4FY26 performance delivered its strongest volume growth in 12 quarters, supported by segment-led gains in Home Care and Beauty & Wellbeing. But higher expenses and a lower EBITDA margin kept the spotlight on cost inflation and pricing constraints. Nuvama retained its ‘Buy’ rating while cutting the target price to Rs 3,090 and trimming FY27 and FY28 EPS estimates. The next key items investors will track include margin progression and the shareholder vote on the final dividend at the upcoming AGM.